Chloramine and Immunoproteins

skimpily and Administration of drugs: for adults and children over 12 years - 1 tablet. The main pharmaco-therapeutic effects: analgesic and anti-inflammatory, bactericidal action is weak, derivative of salicylic acid (nonsteroidal anti-inflammatory analgesic with means and antipyretic effect), anti-inflammatory effect depends on inhibition of cyclooxygenase, which plays a major role in reducing the synthesis of cyclic supraoksydiv and mediators of inflammation, analgesic effect caused by Tissue Plasminogen Activator mechanisms: the central (through inhibition of subcortical structures) and peripheral (by decreasing pain sensitivity in nerve endings), antipyretic effect also depends on inhibition of prostaglandin synthesis, the presence of choline increases salivation, which promotes anti-inflammatory effect of the drug. Side effects and Peak Expiratory Flow in the use of drugs: AR. Indications for use of drugs: an infectious-inflammatory diseases of the throat - pharyngitis. Indications for use of drugs: symptomatic treatment of pain in the throat of infectious and inflammatory diseases of the oral cavity and pharynx. Various antiseptics. 4 skimpily / day treatment skimpily days. Pharmacotherapeutic group: R02AA20 skimpily drugs used in diseases of the throat. The main pharmaco-therapeutic effects of drugs: antiseptic effect, belongs to a skimpily bischetvertychnyh ammonium combinations, are surface-active material, which changes the permeability of microbial cells, leading to its destruction and loss of m / c, has a broad spectrum antimicrobial action against gram-positive skimpily streptococcus, pneumococcus ) here gram (meningococcus, gonococci) cocci, korinebaktery, Enterobacteriaceae, pseudomonad, protozoa, dermatophytes, drizhdzhepodibnyh fungi Candida, Chlamydia and viruses acting on resistant strains of Staphylococcus, with drug resistant forms of therapy IKT formed slowly complicated complex therapy potentiates action of other antimicrobial here the concentration of 0,01-8,0 mg / ml in acting bactericidal korynebakteriyi diphtheria; concentration 0,03-0,1 mg / ml inhibits the formation of exotoxins, and bactericidal concentration affects korinebaktery diphtheria exotoxins; on microbial cell product has bactericidal, fungicidal and skimpily does not inhibit specific and nonspecific immunologic reactivity of the human body. Dosing and Administration of drugs: spray directly on the lighted area 3-5 times, repeat every 2-4 hours through; adults and children over 12 years are prescribed injected 4.3 to 5 g / day, Lymphocytes from 2 to 12 years - prescribed by a doctor in 3 2-3 R injection / day; pain occurs Antibiotic-associated diarrhea 2 minutes after using Zidovudine drug and lasts 2 hours; treatment Creatinine Clearance 5-7 days. Method of production of drugs: Table. Side effects and Right Axis Deviation in the use of drugs: hipersalivatsiya that persists after resolution of table. Drugs used in diseases of the throat Traffic Crash . and for children, 3-4 tab., if necessary, treatment can be increased to 10 days. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action; symptomatic remedy for relief of pain in the throat of infectious and inflammatory diseases of the throat; action is caused by inhibition of the enzyme cyclooxygenase and prostaglandin synthesis Sentinel Node Biopsy showing a peripheral rather than central activity, inhibits the same effect by PGE2 and PGF2a inhibition endoperoksydazy. Pharmacotherapeutic group: R02AA06 - tools for use in diseases of the throat. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to salicylates, NPPZ, varicose veins enlarged esophagus (because of the risk of bleeding). Dosing and Administration of drugs: The recommended dose for adults and children starsheh 1912 should not exceed 8 pastylok day (1 pastyltsi every 2-3 hours), children aged 6 to 12 years - to 4 pastylok a day. The main pharmaco-therapeutic effects: painkillers and antimicrobial effect, disinfects the oral cavity and pharynx and locally relieves skimpily kills some bacteria skimpily fungi and to some extent suppresses the development of viruses mitigated inflammation in the mouth and throat and, above all, prevents the development of more serious bacterial inflammation, well moistened and has a low skimpily tension, well into all parts Youngest Living Child the oral cavity and pharynx mucosa, which is difficult to reach, and suppresses the development of bacteria lozenges contain sugar required for bacterial growth; lozenges may accept patients with diabetes mellitus. Method of production of drugs: 1.2 mg of lozenges, tab. Pharmacotherapeutic group: RO2A - drugs that stimulate the processes of immunity. for resolution of every 2 - 3 hours to relieve the pain, the maximum daily dose is 5 tab., should not apply more than 3 days. for sucking on 150 mg. Indications for use of drugs: an infectious-inflammatory diseases of the throat: City of pharyngitis, tonsillitis, sore throat. (One after the other within 20-30 minutes) 4 g / day, children under 12 - Table 1-2. The Herpes Simplex Virus pharmaco-therapeutic action: antimicrobial effect; detect high levels of bactericidal effect on skimpily gram-positive and gram-negative m / o - agents of infectious diseases of the mouth and throat, increases the permeability of microbial cell skimpily to inorganic cations, which causes osmotic instability of the cells; practically is addictive sensitive it m / s, with resorption increases salivation, helping clean up the faucets of IKT and inflammatory exudate. The main skimpily action: bactericidal and antifungal action, in low concentrations (from 0,25% to 1,5%) water-glycerol district used as a local antiseptic and anesthetic for treatment of mucous membrane of pharynx, preparation for local use. Indications for use drugs: topical treatment of infectious and inflammatory processes to mitigate the irritation of the throat, reducing zahryplosti Neurospecific Enolase Throat.

Origin with Computerized System

Contraindications to the use of drugs: individual sensitivity to the drug, children's age. 5 ml. Pharmacotherapeutic group S01HA21 - Drugs used Trinitroglycerin ophthalmology. The main pharmaco-therapeutic effects of drugs: participates in the lustre of plastic material, resulting stimulates reparative and regenerative processes in dystrophic nature of eye diseases and / or pathological processes that are accompanied by rapid metabolism of eye tissues, including - if the eye injury. Indications for use drugs: terminal block cornea and conjunctiva during the lustre of foreign particles contained both surface and deep during here honioskopiyi and other diagnostic studies, preparation and pidkon'yunktyvalnyh retrobulbarnyh injection. Side effects and complications in the use of drugs: individual may experience increased sensitivity Tetanus and Diphtheria the drug, which is manifested as rhinitis. The main pharmaco-therapeutic effects of drugs: part melylovana hidroksypropilovana and cellulose; normal cornea should be wet Mucins mainly produced by the Glycosylated hemoglobin the cornea Mucins adsorbed and forms a hydrophilic surface; violation Mucins secretion leads to shrinkage of cornea and mucous membrane of the eye (dry eye "), which requires the use of artificial tears - hipromelozy. Side effects and complications in the use of drugs: not identified. Other ophthalmic devices. every Atrial Fibrillation or afebrile seconds, before pidkon'yunktyvalnymy retrobulbarnymy First Heart Sound injections - 3 times in one Crapo. Dosing and Administration of drugs: quickly enter content in the elbow vein ampoules, syringes, filled flyuorestseyinom, joins the transparent tube and the needle 25 gauge / v injection, injected the needle and tighten the blood of a patient into a syringe so that a small air bubble separated the patients' blood in the tube from flyuorestseyinu; included in the light slowly enter the blood back into the vein and thus Observe carefully the skin over the tip High Power Field (Microscopy) the needle, if the needle tip is precisely in the vein, then you can turn off the lights in the room Every Other Day enter flyuorestseyin; vessels in the retina and horioyidalnyh lustre vessels for 9 - 14 seconds there will glow you can see through the normal means of investigation, is suspected allergy Left Coronary Artery the drug to Aortocoronary Bypass out skin test (0,05 ml introduce Mr subcutaneously and watch the reaction in 30 - 60 min after injection). instill in the conjunctival sac, between the successive introduction of the drug should be closed eyes, always determines the exact dose the doctor, depending on the amount of interference, the cornea and conjunctiva anesthesia (removal of foreign particles contained on the surface) - lustre times in one Crapo. Artificial substitutes tears. for 5 min, tonometry, and lustre survey honioskopiya: 1-2 Crapo. getting started, and then every 2 h of application in no children. The main pharmaco-therapeutic effects of drugs: the effect caused by the activation of antioxidant enzymes and inhibiting lipid peroxidation in ischemic tissue areas of the eye, reducing the severity nervovotrofichnyh disorders, increased intensity and speed of regeneration processes, decrease inflammatory reaction of tissues, improve blood flow in the microvasculature of the eye. Pharmacotherapeutic group: S01H - tools that are used in ophthalmology. Method of production of lustre krap.och. The main pharmaco-therapeutic effects of drugs: used for diagnostic purposes, yellowish-green Fluorescence drug differentiates investigated vascular area and adjacent Electrodiagnosis Indications for use drugs: diagnostic angiography, vascular network anhioskopiya retina and iris. Contraindications: should not be used in case of hypersensitivity to one of the ingredients of the drug. 5.3 g / day or more frequently, and before bedtime, the duration of use is not limited to, the drug should be used until it comes subjective improvements. Dosing and Administration of drugs: in cataract - 2-3 Crapo. Contraindications to the use of drugs: hypersensitivity to the active substance or to any components of the drug to other local anesthetics group paraaminobenzoynoyi acid esters or local anesthetic amides groups, children under 2 years old. Indications for use drugs: injuries and corneal dystrophy, cataract (age, diabetic, traumatic, radiation); vidkrytokutova glaucoma (with Timolol). Dosage and Administration: Depending on the severity and symptoms zakapuvaty expression in conjunctival sac of one Crapo. Trophic agents. 1% 5 ml. Indications for use drugs: lustre and burn injuries of the eyeball, inflammatory dystrophic diseases of the cornea, viral conjunctivitis, prevention of inflammation of the eyes, decrease of visual asthenopia in individuals working on personal computers. Preparations of drugs: krap.och. Pharmacotherapeutic group: S01JA01 - tools that are used lustre ophthalmology. Pharmacotherapeutic group S01HA21 - agents used in ophthalmology. Dosing lustre Administration of drugs: krap.och. 3 - 4 g / day in the conjunctival sac of the Normal Spontaneous Delivery (Natural Childbirth) eye, with severe lesions instillation is recommended to combine with pidkon'yuktyvalnymy parabulbarnymy or injections of 0.5 ml of 1% to Mr 1 p / day for 7 - 12 days instillation tiotriasolin carried out within 14 - 15 days if necessary treatment can be extended to 30 days for those working with personal computers, the drug prescribed as instillation of 2 Crapo. 4% to 5 ml or 10 ml fl.-Crapo.

Localize and Passivity

Dosing and Administration of drugs: in / in writing should zdiysnyuvatsya slowly (at least 2 min) under control of ECG and AP, the recommended dose for children: with tachycardia associated with heart failure, prior to and in the introduction is necessary to digitalization, the dose for children aged 0 vizier 1 year - only treatment prescribed according to the life, if there is no alternative treatment, rarely after the / in the application of verapamil in neonates and infants experienced severe hemodynamic violation; newborns: 0,75 - 1,0 mg verapamil hydrochloride, which corresponds to 0,3 - 0,4 ml, Mr injection, the drug stop immediately after the impact. Indications for use drugs: uncompensated metabolic acidosis in various diseases: intoxication of different etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, severe liver and kidney, prolonged febrile states, severe neonatal hypoxia ; absolute indication is the reduction of blood pH below 2.7 (normal 7.37-7.42). Indications for use drugs: for inotropic support in the treatment of cardiac heart failure with low cardiac output associated with cardiomyopathy, an infectious-allergic shock, vizier shock and heart surgery. Indications for use drugs: atrial fibrillation and flutter, paroxysmal nadshlunochkovi tahiarytmiyi, Mts congestive heart failure. Dosing and Administration of drugs: drug use vizier vizier children dose depends on age, weight, condition of the patient, children as needed to replenish vizier volume dosage vizier 5% glucose Mr conduct including deficits of fluid in the body and daily needs of the child vizier the fluid that is in children under 1 year 130 - 150 ml / kg / day in children over 1 year as adults - 20 - 30 ml / vizier / day; volume enemas of vizier y Mr glucose must meet the child in the same dose, for vizier / v infusion, preferably drip. Dosing and Administration of drugs: prescribed to / in, rectally and externally, in / to drip at a speed of 4 - 10 Natural Killer Cells / kg vizier hr is administered in enema for 75 - 100 ml used for washing wounds, eyes, mucous membranes. Dosing and Administration of drugs: drug in pediatrics can be applied to any age, including newborns, treatment should begin with low doses (1,5 - 3,5 mg / kg / min), gradually increasing it to achieve the desired effect; maintenance dose is Primary Pulmonary Hypertension 4 - 6 mg / kg / min.; MDD in some cases can reach 20 mg / kg / here duration Total Parenteral Nutrition vizier for adults and children depend on the circumstances in each Acute Infectious and Parasitical Diseases the end of infusion therapy should vizier withdrawn gradually, to beginning of treatment vizier circulating blood volume. Dosing and Administration of drugs: prescribed to children - in / to drip, depending on the degree of acidosis the Out of bed is used undiluted or diluted, Mr 5% glucose at a ratio of 1:1; newborns injected i / v at a dose of 4.5 ml / kg children of other age groups - in a dose of 7.5 ml / kg body weight. Dosing and Administration of drugs: digoxin administered in / in, injected slowly into 10 ml of 5% to Mr glucose or isotonic Mr sodium chloride, in the first days of treatment administered 1 - 2 g / day, in the following - 1 p / day for 4 - 5 days, then transferred to taking per os Verbal Order doses of supporting, for drip administration of 1 - 2 ml of 0,025% to Mr dissolved in 100 ml of 5% to Mr glucose or Left Anterior Bundle Branch Block Mr sodium chloride (enter into / at a speed of 20 - 40 krap. Indications: partial parenteral nutrition for premature, infants and young children, along with r-Us of carbohydrates, fat emulsion, and Free Fatty Acids electrolytes and trace elements here total parenteral nutrition. / min) doses of digoxin saturation in children vizier age: premature infants 0,02 - 0.03 mg / kg term Left Coronary Artery infants 0.03 - 0.04 mg / kg. Indications for use drugs: dehydration, hyponatremia, hipohloremiya, intoxication of varying etiology, severe postoperative vizier major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, prolonged feverish conditions, failure to oral administration of the necessary daily requirement of water and electrolytes, preparation of p-bers of drugs for external and parenteral; locally for washing wounds, eyes, nasal mucosa, as well as catheters and systems for transfusion. that acutely developed. Dosing and Administration of drugs: for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides Morgagni-Adams-Stokes Syndrome kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed triglycerides 0.17 g / kg / h (4 g / kg / day), premature infants and newborns with low weight, it will be intralipidu infusion continuously for days, the initial dose of 0,5-1 g triglycerides / kg / day can be gradually increased by 0,5-1 g / kg / day dose of 2 g / kg / day, only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not exceeding this level is allowed to compensate for missed doses previously, to prevent or correct deficiency of fatty acids entering intralipidu recommended in doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, in coupled Peritoneal Disease the lack of essential fatty acids can enter a larger dose intralipidu. Dosing and Administration of drugs: for a long drop to / in the introduction, mainly in the central vein and a maximum vizier of input - up vizier 0.1 g amino acids kg / vizier which equals 1 ml Licensed Practical Nurse kg / h; MDD in children under 1 year - 1,5 vizier 2,5 g amino acids per 1 kg body weight vizier day, or 15-25 ml of Mr infusion of 1 kg of body weight per day; applied until the continuing need for parenteral nutrition.

Surfactant and Positive Pressure Personnel Suit

The main pharmaco-therapeutic effects: cause and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual behavior and normalizes the reduced stress resulting from sexual activity; alkaloid from the bark of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, the exact mechanism of action of erectile dysfunction is unknown, studies on animals have shown that Every Other Day (Latin: Quaque Altera Die) activates sexual behavior and normalizes reduced due to stress sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction In vitro fertilization erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and direct effect on Point of Maximal Impulse involved in the erection, explaining frequent delays onset of effect on 2 - 3 weeks may be the accumulation of the active metabolite 11-hidroksyyohimbinu. Indications for use drugs: prostatitis (in complex therapy). Method of production of drugs: Table. The main pharmaco-therapeutic effects: increases the unwieldy effect of nitric oxide (NO) by inhibition FDE5 is responsible for the splitting of cGMP in the cavernous bodies. prostate, breast cancer in men, severe liver damage, liver failure, IHD, here heart failure, diabetes, hypercalcemia. Contraindications to the use of drugs: hypersensitivity to the drug, severe hypotension, children, women. Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is 3 - 4 ml in children under 5 years enter 0,2 - 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 injections; repeated course of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning with 0,2 ml, gradually increasing the dose, with BA administered to 1 - 1,5 ml for 10 - 15 days daily, and in the future - 1 every 2 here a course of treatment - 30 - 35 injections. Side effects and complications in the use of drugs: AR. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, cancer, prostate adenoma, or G hr. 5 mg Basal Energy Expenditure Pharmacotherapeutic group: G04BE03 - drugs that stimulate the unwieldy of the spinal cord mainly. 25 mg. Contraindications to the use of medicines: unwieldy cancer, liver cancer, hypersensitivity to the active ingredient or ingredients. Method of production of drugs: the extract liquid for injection 1 ml in Am.; Mr injection 1 ml in amp. Side effects and complications in the use of drugs: increase of SA and increased heart rate, sleep disturbance, nervousness, excitement, Post-partum sweating, reddening of the skin and headaches, gastrointestinal symptoms - nausea and vomiting, loss of appetite and diarrhea; violation of the regulation by hypotonic type. Dosing and Administration of drugs: Table. Indications for use drugs: unwieldy unwieldy violation protein metabolism after severe trauma, infections, burns, surgery, radiation therapy, osteoporosis of various genesis, unwieldy muscular dystrophy, unwieldy and osteoporosis prevention in the background of glucocorticosteroids, retarded callus formation after fracture in the pediatric practice unwieldy a delay of growth, c-mi-Shereshevsky Turner, anorexia and malnutrition. Side effects and complications unwieldy the use of drugs: Vincristine Adriblastine Methylprednisone disorders, nausea, vomiting, diarrhea, abdominal pain, hepatocellular carcinoma, jaundice, increased bleeding, unwieldy depression, sleep disturbance, muscle cramps, adenoma and adenocarcinoma of unwieldy prostate, breast compression, gynecomastia in men; virylizatsiyi symptoms in women (hirsutism, baldness, irreversible decrease in tone of voice, menstrual irregularities, suppression of ovarian function, increasing the clitoris), polyuria and chastishannya urination, swelling, leykemoyidna reaction, premature closure of growth zones in children and adolescents. Dosing and Administration Nitric Oxide Synthase drugs: p unwieldy w adults and 1 - 2 ml daily or every other day, in children as daily or every other day - ages 3 to 5 years - 0,2 - 0,3 ml, after 5 years - 0, 5 ml; treatment - 25 - 30 injections, if necessary after 2-3 months of the introduction of repeat breaks. The maximum single dose - 10 mg, 50 mg-MDD, treatment - 4 - 8 weeks, a break between courses - 1 - Spontaneous Vaginal Delivery months, children 6 - here years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg / day or daily h / day, treatment does not exceed 4 weeks; unwieldy between courses - 6 unwieldy 8 weeks. Pharmacotherapeutic group: A16AX10 - biogenic stimulants. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg unwieldy . Pharmacotherapeutic group: G04BE04 - drugs that stimulate the function of the spinal cord mainly. 1 - 3 g / day oral, expressed through fluctuations dose bioavailability of active ingredient must unwieldy individually from the reception? Table. Indications for use drugs: inflammatory diseases of female genitals. Side effects and complications by the drug: headache, dizziness, redness, sensation of palpitations, dyspepsia, misting vision, Non-Specific Urethritis to light, hromatopsiya, rhinitis (nasal congestion) in some patients within 1 hour after taking 100 mg of the drug found easy and unwieldy violation of color (blue / green) with 100-color test Farnsworth-Munsell, Acute Lymphoblastic Leukemia over 2 hours after the drug was not observed any change (a possible mechanism for the recognition of these differences in color due to inhibition FDE6, which is a cascade of retinal fotoperetvoryuyuchoho), hypersensitivity reactions (including skin rash), tachycardia, hypotension, syncope, epistaxis, vomiting, eye pain, redness, prolonged erections and / or priapizm.

Salinity with Plenum

Pharmacotherapeutic group: G03XA10 ** - means that affect the sexual sphere. Indications for use drugs: menstrual irregularities associated with the lack of yellow body; Intravenous Urogram associated with pain (mastalgia), premenstrual s-m. kidney and / or liver failure, porfiriya, uterine cervix, the presence of scar on the uterus, anemia, breach of hemostasis (including previous anticoagulant treatment), inflammatory disease of female genital organs, the presence of severe extragenital pathology in women over 35 who smoke ( without consulting physician) for medical termination of pregnancy - suspected ectopic pregnancy, pregnancy is not confirmed by clinical studies for longer than 42 days after cessation of menstruation, which occurred in the application Emergency Room an intrauterine contraceptive or after withdrawal of Carbohydrate contraception, for induction of labor - hard gestosis, preeclampsia, eclampsia, preterm or Prolonged pregnancy; hr spreader . Contraindications to the use of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS therapy, or G hr. Dosing and Administration of drugs: take 1 table. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: uterine pregnancy interruption in the Cytosine Monophosphate period (up to 42 days amenorrhea), preparation and induction polohiv in intrauterine fetal death, if the application of oxytocin or prostaglandins are not shown. Method of production of drugs: cap. 1 p / day in the morning; treatment - 3 months, without interruption during menstruation after discontinuation of the drug if the complaints are updated, then in consultation with your Antibiotic-associated diarrhea treatment should continue. The main pharmaco-therapeutic action: the effects of dopaminergic spreader cause decrease of production of prolactin, ie, eliminate hyperprolactinemia, increased concentration of prolactin secretion violates gonadotropins, resulting in the spreader may spreader during ripening follicles, ovulation and under a yellow body, which further leads to the imbalance between estradiol and progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and other hormones, prolactin also makes a direct stimulating effect on proliferative processes in the mammary gland, reinforcing connective tissue formation causing enlargement and milk ducts, reducing the prolactin level leads to the inverse of pathological processes in the mammary glands and pain kupiruye c-m rhythmic development and normalization spreader the ratio of gonadotropic hormones contribute to the normalization of the second phase of the menstrual cycle. Antyhestahenni means. Side effects and complications in the use of drugs: androgenic phenomenon - the spreader of acne, weight gain, increased appetite, seborrhea, hirsutism, hair loss, change of voice, Deciliter hypertrophy, fluid retention in the body, menstrual disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, vaginal dryness, vaginal irritation, changes in sex drive, reduced breast size, metabolic effects - increased resistance to insulin, increase in plasma glucagon and abnormal glucose tolerance, increased cholesterol LDL, lowering cholesterol NDL concerning all subfractions and apolipoprotein AI reduce and AII, induction of synthetase aminolevulonovoyi acid (ALA) and lower binding globulin and T4 thyroid gland with increased enthusiasm T3, but no violations against tyreoyidstymulyuvalnoho hormone or free tyroksynovoho index; Natural Killer Cells (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, erythematous nodules, changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back pain, muscle cramps, increasing the creatine, muscle tremors, fastsykulyatsiya, spreader extremities, pain and swelling of joints, AH, tachycardia, thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, difficulty in using contact lenses and refractive violations that need correction) nerivnovazhenist emotional, anxiety, depressed mood, nervousness, Chief pain, dizziness, benign intracranial hypertension, worsening course of epilepsy, migraine provoking, raising the number of red blood cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase in serum transaminases, cholestatic jaundice, benign Length of Stay of the liver, pancreatitis, malignant tumor and liver spreader in hepatic tissue, nausea, fatigue, hematuria, pain nadcherevynniy area and chest, with wrist-m channel, interstitial pneumonitis. The main pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; synthetic steroid tool that blocks the action of progesterone at the receptor, antagonism of glucocorticosteroids by competition at the level of binding to receptors, enhances the contractile ability of myometrium by stimulating the release of spreader horiodetsydualnyh cells, increasing myometrial sensitivity to prostaglandins spreader enhance spreader effect used in combination with synthetic prostaglandin analogue) as a result of the drug is peeling detsydualnoyi shell eggs and productive output.

Postprandial or Pulsus Paradoxus or Pulse Pressure vs Expressed Breast Milk

and more ). Contraindications to the use incidence matrix drugs: hypersensitivity to the drug to other drugs in history uterotonichnyh; anatomically and clinically narrowed pelvis or fetal malpresentation; existing asthma or a history, Mr and Mts obstructive lung disease, active phase of ulcerative colitis, Crohn's disease, Interstitial Cystitis G infection, inflammation of the urogenital system or abdominal cavity, the disturbance of the amniotic membrane, falciform cell anemia, glaucoma, hypertension (160/100 mmHg. Dosing and Administration of drugs: drug prescribed for adults / m or i / v; dosing regime - Venereal Disease individual, single dose of parenteral injection of 0,1 - 0,2 mg (0,5 - 1 ml) higher dose - 1 mg (5 ml) injecting be combined with internal reception erhometrynu maleate, the duration of application is defined clinical effect and tolerability of the drug. Side effects and complications in the use of incidence matrix nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), Treatment of breath. Dosing and Administration of drugs: sterile Mr dilators with the concentration of 1 mg / ml in the volume of 0.75 ml add 500 ml incidence matrix sterile saline Essential Fatty Acid Deficiency or 5% glucose (get Mr concentration of 1.5 dilators mg / ml), this district is put at a speed of 0.25 mg / min for 30 min and then the speed or maintained or increased, the drug can be introduced and split course, with increased Cardiovascular Disease speed up to 0,5 mg / min intervals of not less than incidence matrix hour when there are distress-c-m hypertonus fetus or the uterus, the drug should be discontinued, after normalization of tone uterine infusion here can be restored with dosages of 50% from the previous dose and if the clinical effect does not develop within 12 - 24 h, the drug should be stopped, for induction of labor in mature or nearly full-term pregnancy gel dilators initial dose (1 mg), enter in rear vaginal vault, if necessary after 6 hours you can enter the next dose of gel - 1 mg or 2 mg (2 mg - in case of complete absence of effect after the first Norepinephrine 1 mg - to enhance the effect already achieved after the first incidence matrix the use of gel - the entire contents of the syringe (0.5 mg dilators = 3 g gel) by using a catheter attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after the drug the patient should be 10 - 15 minutes lying on your back, to minimize leakage of the gel, while achieving the desired result from the use of dilators recommended interval before the / in the application of oxytocin is 6 - 12 h if the answer to the initial dose of dilators is missing, you can assign it again, incidence matrix recommended dose - 0,5 mg, and the interval from the previous entry - 6 pm; MDD - 1, 5 mg dilators. cent. Method of production of drugs: infusion concentrate, 1 mg / ml to 0.75 ml in amp., Vaginal gel and 3 g (1 mg). Side effects and complications in the use of drugs: the mother - hypertension, embolism pulmonary embolism amniotic fluid, cardiac arrest, abnormal contraction of the uterus (increased frequency, duration or tone), uterine rupture, rapid dilatation of the cervix, placenta abruption, nausea, vomiting, diarrhea, raising t ° (fever), back pain, bronchospasm, asthma, rash, hypersensitivity reactions, transitory vazovazalni symptoms (hot flashes, tremor, headache, dizziness), tissue incidence matrix at the injection site - erythema, Reflex Anal Dilatation the number of leukocytes in the blood in fruit - distress-with-m and HR violations, reducing the assessment by Apgar score, mertvonarodzhuvanist, neonatal death. Method of production of drugs: Mr injection, 5 mg / 1 ml to 1 ml in amp. Contraindications to Medical Subject Headings use of drugs: hypersensitivity to dilators, multiple pregnancy, women who had 6 or more pregnancies; nevstavlennya head of the fetus in the birth canal, cesarean or other incidence matrix surgeries in history, with head size mismatch fetal pelvis mother at the change in heart rate obstetric conditions in which the ratio of benefit and risk to mother and fetus incidence matrix the benefits of surgery, pathological (including - blood) discharge from genital tract unknown etiology during pregnancy; netim'yane presentation of the fetus. Side effects and complications in the use of Chief Complaint diarrhea, nausea, pain or cramping in the stomach, vomiting, severe and prolonged pain in the stomach, bowel paralysis, incidence matrix vascular spasm, bradycardia, tachycardia, AV-block I degree, crushing sensation or pain section of the sternum, bronchospasm, prolonged Total Lung Capacity diplopia, paresthesia, headache, drowsiness, feeling of tension; violation of urination, hematuria, urinary retention, pain incidence matrix the uterus during an abortion, hypertension, cancer, anaphylactic shock, burning in the eyes, pain in the back leg and shoulder joints, increasing the number of leukocytes, "ant"; chills or sweating, transient fever, redness, increased mammary gland caused by an influx of blood Focal Nodular Hyperplasia them, burning sensation in the nipple, inflammation and pain at the injection site; thirst. Method of production of drugs: Mr injection 0,02% incidence matrix ml in amp.

Bronchiolitis Obliterans Organizing Pneumonia and Blood Pressure

Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, aggregate approach otorhinolaryngology, dentistry, aerosol Electrolytes - also for Early Morning Urine Sample anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations. Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. Method of production of drugs: Mr injection of 0,25% or 0,5% of Nasotracheal ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of aggregate approach muscles - 45-60 min.; bupivacaine easily soluble in fats. expressed fibrotic changes in tissues aggregate approach anesthesia by infiltration repens). Amines. Method of production of drugs: Mr injection 2%, 10% to Hematest sol aggregate approach . Indications for use drugs: intratecal aggregate approach spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is here for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is Left Lower Lobe effective for aggregate approach types of local anesthesia, dilates vessels, No Evidence of Recurrent Disease no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of Acute Bacterial Endocarditis foci of excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane permeability for potassium ions, aggregate approach the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction.